Publikationen von Schöffski, P.

Schmoll, H.-J., Kollmannsberger, C., Metzner, B., Hartmann, J. T., Schleucher, N., Schöffski, P., Schleicher, J., Rick, O., Beyer, J., Hossfeld, D., Kanz, L., Berdel, W. E., Andreesen, Reinhard und Bokemeyer, C. (2003) Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21 (22), S. 4083-91. Volltext nicht vorhanden.

Köhne, C. H., Schöffski, P., Wilke, H., Käufer, C., Andreesen, Reinhard, Ohl, U., Klaasen, U., Westerhausen, M., Hiddemann, W., Schott, G., Harstick, A., Bade, J., Horster, A., Schubert, U., Hecker, H., Dörken, B. und Schmoll, H. J. (1998) Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 16 (2), S. 418-26. Volltext nicht vorhanden.

Köhne, C. H., Wilke, H., Hecker, H., Schöffski, P., Käufer, C., Rauschecker, H., Andreesen, Reinhard, Ohl, U., Lange, H. J. und Klaassen, U. (1995) Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 6 (5), S. 461-6. Volltext nicht vorhanden.